Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-8744
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients ; volume:46 ; number:5 ; day:21 ; month:5 ; year:2019 ; pages:427-438 ; date:10.2019
Journal of pharmacokinetics and pharmacodynamics ; 46, Heft 5 (21.5.2019), 427-438, 10.2019
- Urheber
-
Chelle, Pierre
Yeung, Cindy H. T.
Bonanad, Santiago
Morales Muñoz, Juan Cristóbal
Ozelo, Margareth C.
Megías Vericat, Juan Eduardo
Iorio, Alfonso
Spears, Jeffrey
Mir, Roser
Edginton, Andrea
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10928-019-09637-4
- URN
-
urn:nbn:de:101:1-2020021819053890993230
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chelle, Pierre
- Yeung, Cindy H. T.
- Bonanad, Santiago
- Morales Muñoz, Juan Cristóbal
- Ozelo, Margareth C.
- Megías Vericat, Juan Eduardo
- Iorio, Alfonso
- Spears, Jeffrey
- Mir, Roser
- Edginton, Andrea
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Two different approaches for pharmacokinetic modeling of exhaled drug concentrations
Home Treatment for Children with Hemophilia
Serpins, New Therapeutic Targets for Hemophilia
Pharmacokinetic–pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice
Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Two different approaches for pharmacokinetic modeling of exhaled drug concentrations
Home Treatment for Children with Hemophilia
Serpins, New Therapeutic Targets for Hemophilia
Pharmacokinetic–pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice
Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Two different approaches for pharmacokinetic modeling of exhaled drug concentrations
Home Treatment for Children with Hemophilia
Serpins, New Therapeutic Targets for Hemophilia
Pharmacokinetic–pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice
Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy